Study of Imatinib in Children With Neurofibromatosis and Airway Tumors

NCT03688568 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Enrollment not feasible

Conditions

Neurofibroma, Plexiform

Interventions

DRUG: Imatinib Mesylate

Sponsor

Indiana University